Mathematical Prediction of the Efficacy of Medicinal Products in Preclinical Studies
Generally, preclinical studies of medicines conducted in accordance with national and international regulatory recommendations allow minimising the risks of detecting serious adverse events in patients at the stage of clinical trials. Nevertheless, current analytical trends motivate the development...
Main Authors: | O. V. Shreder, N. D. Bunyatyan, D. V. Goryachev, R. D. Subaev, G. N. Engalycheva, A. D. Kuznetsova, V. V. Kosenko |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (FSBI ‘SCEEMP’)
2022-10-01
|
Series: | Регуляторные исследования и экспертиза лекарственных средств |
Subjects: | |
Online Access: | https://www.vedomostincesmp.ru/jour/article/view/462 |
Similar Items
-
EXPERT EVALUATION OF PRECLINICAL STUDIES OF PRIMARY AND SECONDARY PHARMACODYNAMICS OF MEDICINES
by: G. N. Engalycheva, et al.
Published: (2018-12-01) -
Quality Standards of Preclinical Pharmacological Studies
by: G. N. Engalycheva, et al.
Published: (2019-12-01) -
WoE Analysis and Key Risk Factors in Preclinical Development of Medicinal Products: A Review
by: G. N. Engalycheva, et al.
Published: (2024-12-01) -
High Dose Selection for General Toxicity Studies of New Medicines
by: G. N. Engalycheva, et al.
Published: (2023-06-01) -
Investigation of the fabomotizol dihydrochloride effect on the morphological picture of the heart left ventricle in rats with the subacute myocardial infarction
by: I. A. Miroshkina, et al.
Published: (2022-02-01)